Evidence map›Paper›PMID 42282834›Full record

ArticlebioRxiv : the preprint server for biology2026

Differential vulnerability of CA1 pyramidal neuron cell types in the 5xFAD Alzheimer's disease mouse model.

Maricarmen Pachicano, Angela Hurtado, Shrey Mehta, Bayla Breningstall, Yiwen Zhou, Michael S Bienkowski

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maricarmen PachicanoStevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0000-0003-4290-2056
Angela HurtadoStevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0009-0006-4303-3891
Shrey MehtaStevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0009-0002-9353-7781
Bayla BreningstallStevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0009-0009-6002-1501
Yiwen ZhouStevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA.
Michael S BienkowskiStevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA.ORCID 0000-0002-8231-8893

Funding

Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's DiseaseP01AG052350 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Marcelo Pablo Coba · 2016 to 2026
$28.4M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI · 2020 to 2026
$27.8M
High Capacity, High Performance Storage System for NeuroscienceS10OD032285 · OD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TOGA, ARTHUR W · 2022 to 2022
$1.7M
Multiscale Modeling of Hippocampus Vulnerability to Alzheimer's Disease Neurodegeneration.R01AG092662 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Michael Bienkowski · 2026 to 2026
$696k
A Translational 3D Map of Hippocampal Cell Types To Drive Investigations of Alzheimer's DiseaseK01AG066847 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BIENKOWSKI, MICHAEL · 2021 to 2025
$629k
CA1 cell-type susceptibility in Alzheimer'sR36AG087310 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PACHICANO, MARICARMEN · 2024 to 2024
$52k
NIA NIH HHS K01 AG066847NIA NIH HHS P01 AG052350NIA NIH HHS P30 AG066530NIA NIH HHS R01 AG092662NIA NIH HHS R36 AG087310NIH HHS S10 OD032285
6 · The paper itself

Abstract

Selective neuronal vulnerability is a defining feature of Alzheimer's disease, yet how neurodegeneration unfolds across defined hippocampal CA1 pyramidal neuron populations remains unresolved. Previously, we showed that CA1 pyramidal neurons are organized into molecularly defined laminar cell types that form stable spatial signatures along the longitudinal axis (Pachicano et al., 2025). Here, we investigated how vulnerability manifests across CA1 pyramidal cell types in the 5xFAD mouse model of amyloid pathology. HiPlex single-molecule fluorescence in situ hybridization was used to quantify gene expression at single-cell resolution across hippocampal CA1 subregions across disease progression. Cells were classified into molecularly defined CA1 pyramidal cell types based on marker gene expression, and changes in density, proportion, and molecular state were assessed. Amyloid-associated pathology differentially affected CA1 pyramidal cell types, revealing distinct trajectories of vulnerability and resilience. Specific populations exhibited early and progressive susceptibility, while other populations demonstrated relative preservation across disease timepoints. These effects were consistent across CA1 subregions, indicating that vulnerability follows cell type identity rather than regional anatomy alone. Together, these findings demonstrate that neurodegeneration in Alzheimer's disease is structured by intrinsic cell type identity and provide a cellular framework for understanding selective vulnerability.

Identifiers

PMID42282834
PMCPMC13251927

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.